Related Experiment Video
Updated: May 28, 2026
10:13
Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach
Published on: February 14, 2014
Executive dysfunction and treatment response in late-life depression.
Monique A Pimontel1, Michelle E Culang-Reinlieb, Sarah S Morimoto
1Queens College, City University of New York, NY, USA.
International Journal of Geriatric Psychiatry
|October 20, 2011
Summary
Specific executive functions, verbal fluency and response inhibition, predict poor antidepressant treatment response in geriatric depression. These cognitive deficits may stem from disruptions in frontostriatal limbic circuits.
Area of Science:
- Neuroscience
- Geriatric Psychiatry
- Cognitive Psychology
Background:
- Executive dysfunction is a known predictor of poor treatment response in geriatric depression.
- Identifying specific cognitive deficits is crucial for optimizing antidepressant therapy.
Purpose of the Study:
- To review and clarify which specific aspects of executive functioning predict poor antidepressant treatment response in older adults with depression.
Main Methods:
- A comprehensive literature review was conducted to synthesize existing research.
Main Results:
- Verbal fluency and response inhibition were identified as key executive functions associated with antidepressant response rates.
- The semantic strategy component may influence verbal fluency's impact, though further research is needed.
- Processing speed's role in the relationship between executive dysfunction and treatment response requires further investigation.
Conclusions:
- Verbal fluency and response inhibition are specific executive functions that significantly impact antidepressant treatment outcomes in geriatric depression.
- Disruptions in the frontostriatal limbic circuit, including the anterior cingulate and dorsolateral prefrontal cortex, may underlie these cognitive-treatment relationships.
Related Concept Videos
01:30Cognitive Development During Adulthood
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:30Attention-Deficit/Hyperactivity Disorder
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.